Company: PGEN
Filing Date: 2025-05-14
Form Type: 10-Q
Source: 0001356090-25-000019
Chunk: 13

Company: PRECIGEN, INC.
Filing Date: 2025-05-14
Form: 10-Q
Item: Part I, Item 1
Chunk 13
---
Item 1. Condensed Consolidated Financial Statements

Precigen, Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

(Unaudited)

(Amounts in thousands, except share data)March 31,2025December 31,2024AssetsCurrent assetsCash and cash equivalents$6,058 $29,517 Short-term investments74,184 68,393 ReceivablesTrade, less allowance for credit losses of $0 as of both March 31, 2025 and December 31, 2024751 926 Other313 237 Prepaid expenses 3,295 3,341 Total current assets84,601 102,414 Long-term investments750 — Property, plant and equipment, net14,668 13,831 Intangible assets, net4,136 4,455 Goodwill19,139 19,139 Right-of-use assets5,066 5,056 Other assets427 371 Total assets$128,787 $145,266 

The accompanying notes are an integral part of these condensed consolidated financial statements.

4

Table of Contents

Precigen, Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

(Unaudited) 

(Amounts in thousands, except share data)March 31,2025December 31,2024Liabilities, Mezzanine Equity and Shareholders' (Deficit) EquityCurrent liabilitiesAccounts payable$3,107 $3,531 Accrued compensation and benefits9,621 8,417 Other accrued liabilities6,568 4,812 Indemnification accruals3,213 3,213 Deferred revenue549 589 Current portion of lease liabilities928 956 Total current liabilities23,986 21,518 Deferred revenue, net of current portion1,836 1,934 Lease liabilities, net of current portion4,489 4,546 Warrant liabilities83,018 50,537 Total liabilities113,329 78,535 Commitments and contingencies (Note 13)Mezzanine equitySeries A Preferred Stock, no par value, 81,000 shares authorized as of March 31, 2025 and December 31, 2024; 79,000 shares issued as of as March 31, 2025 and December 31, 2024; aggregate liquidation